← All sessions

Friday In-Focus · 18 Sept 2026

Mind the Gap: The Biggest Threat in MedTech Cybersecurity That No One Is Talking About

Why medtech cybersecurity fails at handover: manufacturers publish security information, hospitals cannot reliably receive it, and both sides need a traceable communication channel.

Plays from YouTube when you press play. Cookie settings

What the session covered

Hosted by Sean Smith, this MedTech Leading Voice session examined the communication gap between medical device manufacturers and hospitals in post-market cybersecurity. Michelle from MedSec argued that the main threat is not a lack of security information but the absence of a reliable way to deliver it. Manufacturers produce advisories, patches, end-of-support notices, MDS2 forms and SBOM data, yet hospitals receive only what they happen to find through portals, bulk email, public disclosures or personal contacts. Portals are rarely visited, email is filtered or blocked during incidents, public postings rely on hospitals searching, and phone calls do not scale. Deborah, formerly of Mayo Clinic, described the hospital burden: technology management teams must work out whether they own a product, what action is required and when to look again, across hundreds of manufacturers. Matt, formerly at FDA and now at MedSec, outlined growing post-market oversight through 524B, QMSR expectations and the principle that responsibility continues while a device remains in the field. The session introduced Bridge, an independent platform that routes information by product ownership and records whether hospitals have responded. The takeaway was direct: communication must be designed, tested and resourced before an incident, and both sides need a single, traceable channel rather than an Easter egg hunt.

Figures

Figures the speakers cited

100users per month one major manufacturer sees on its customer portal, against a customer base in the thousands
120clients globally MedSec works with
24 yearstime Deborah spent at Mayo Clinic
8 yearstime Matt spent on the FDA side
2014year FDA released its first pre-market guidance on shared responsibility
2023year FDA's 524B requirements went into effect
about a dozenlargest manufacturers MedSec has been working with behind the scenes

Source: Michelle

Chapters

Jump to a moment

  1. Upcoming sessions and speaker introductions
  2. Why cybersecurity communication is the focus
  3. Current channels: portals, email, MDS2 and distribution lists
  4. Hospital technology management's search burden
  5. Install-base visibility and manufacturer polls
  6. FDA oversight, 524B and post-market responsibility
  7. Bridge: push notifications, dashboards and receipts
  8. Audience questions on legacy devices and responsibility
  9. Adoption status and closing call to action

Times run from the start of the recording.

Take these with you

Six checks

Test your install-base listTry to produce a list today of every hospital that owns your highest-volume product and check its accuracy.
Audit communication channelsAssume hospitals will not regularly visit portals or successfully receive bulk email.
Push product-specific noticesRoute advisories, patches and end-of-support notices to the hospitals that own the affected product.
Keep MDS2 forms currentTreat MDS2 forms as living documents that stay linked to the relevant product and software version.
Rehearse incident communicationInclude customer notification and receipt tracking in incident-response tabletop exercises.
Plan for legacy and end-of-support riskDo not assume that stopping sales or reaching end of support removes responsibility for a device's security risk.

Full recording

56:16

Plays from YouTube when you press play. Cookie settings

How to cite this session

Jump, M., Hazelett, M., Bruemmer, D. (2026, September 18). Mind the Gap: The Biggest Threat in MedTech Cybersecurity That No One Is Talking About [Webinar]. MedTech Leading Voice, Friday In-Focus. medtechleadingvoice.com/watch/2026-09-18-mind-the-gap-the-biggest-threat-in-medtech-cybersecurity-that-no-one-is-talking-about

Earlier sessions

13 Nov 2026Architecting a Claims Support System 6 Nov 2026Methodological Quality and Scientific Validity Under the MDR 30 Oct 2026AI Pre-Submission Review Under the MDR

Latest issues

Issue 190FDA and the Future of Generative AI Medical Devices Issue 189MDR and IVDR Evidence Requirements in Transition Issue 188Industry Groups Back a Single Regulatory Pathway for AI-Enabled Medical Devices